PROKIDNEY CORP. Quarterly Operating Income (Loss) in USD from Q1 2021 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Prokidney Corp. quarterly/annual Operating Income (Loss) history and growth rate from Q1 2021 to Q3 2024.
  • Prokidney Corp. Operating Income (Loss) for the quarter ending September 30, 2024 was -$49M, a 5.05% decline year-over-year.
  • Prokidney Corp. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$156M, a 0.78% increase year-over-year.
  • Prokidney Corp. annual Operating Income (Loss) for 2023 was -$152M, a 0.97% increase from 2022.
  • Prokidney Corp. annual Operating Income (Loss) for 2022 was -$153M, a 178% decline from 2021.
  • Prokidney Corp. annual Operating Income (Loss) for 2021 was -$55.1M, a 104% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 -$49M -$2.36M -5.05% Sep 30, 2024 10-Q 2024-11-12
Q2 2024 -$43.1M -$3.24M -8.13% Jun 30, 2024 10-Q 2024-08-09
Q1 2024 -$40.1M +$800K +1.96% Mar 31, 2024 10-Q 2024-05-10
Q4 2023 -$24.2M +$6.03M +19.9% Dec 31, 2023 10-K 2024-03-22
Q3 2023 -$46.6M -$11M -31.1% Sep 30, 2023 10-Q 2024-11-12
Q2 2023 -$39.8M -$19.1M -92% Jun 30, 2023 10-Q 2024-08-09
Q1 2023 -$40.9M +$25.6M +38.5% Mar 31, 2023 10-Q 2024-05-10
Q4 2022 -$30.2M +$7.79M +20.5% Dec 31, 2022 10-K 2024-03-22
Q3 2022 -$35.6M -$18.5M -108% Sep 30, 2022 10-Q 2023-11-14
Q2 2022 -$20.7M -$20.7M Jun 30, 2022 10-Q 2023-08-10
Q1 2022 -$66.5M -$66.5M Mar 31, 2022 10-Q 2023-05-11
Q4 2021 -$38M Dec 31, 2021 10-K 2024-03-22
Q3 2021 -$17.1M Sep 30, 2021 10-Q 2022-11-14
Q2 2021 -$143* Jun 30, 2021 10-Q 2022-08-12
Q1 2021 -$5.18K* Mar 31, 2021 10-Q 2022-05-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.